Abstract

Waters Corporation will report third quarter results on November 03, 2026 Pre-MKt; this preview synthesizes last quarter’s performance, segment dynamics, and consensus expectations for revenue, margins, and EPS alongside institutional commentary.

Market Forecast

Consensus embedded in current-quarter forecasts points to revenue of 1.75 billion US dollars with an estimated year-over-year growth of 124.56%, EBIT near 514.76 million US dollars with year-over-year growth of 115.23%, and EPS of 3.997, implying 24.76% year-over-year growth; where available, these forecasts imply margin expansion and improved profitability versus the prior year. Waters’s main business is expected to benefit from a recovery in instrument demand and stable service activity, with improved conversion of backlog and shipment normalization. The most promising segment is Products, with a last-quarter revenue base of 1.22 billion US dollars and a recovery thesis tied to double-digit year-over-year growth implied by the current-quarter revenue forecast.

Last Quarter Review

Waters’s previous quarter delivered revenue of 1.65 billion US dollars, a gross profit margin of 53.98%, net profit attributable to the parent of negative 136.00 million US dollars, a net profit margin of negative 8.27%, and adjusted EPS of 3.05, with year-over-year growth of 3.39%. One notable highlight was the company’s ability to outperform internal and external revenue forecasts despite a challenging demand environment, evidenced by a moderate positive surprise on revenue and EBIT. By business mix, Products generated 1.22 billion US dollars and Services 425.00 million US dollars, with Products the primary revenue engine and Services providing resilient recurring revenue support.

Current Quarter Outlook

Main business trajectory

The company’s core portfolio in analytical instruments and consumables continues to anchor performance as shipment timing and backlog conversion normalize through the quarter. With the current-quarter revenue forecast at 1.75 billion US dollars, momentum implies healthy order intake and improved shipment cycle times compared with last year’s trough. The forecasted EBIT of 514.76 million US dollars signals greater operating leverage on revenue normalization and disciplined cost control, setting the stage for incremental margin recovery. This aligns with improved adjusted EPS forecasts at 3.997, which indicates better mix and operating efficiency alongside steady service attach rates.

Most promising business and growth vectors

Products stands out as the cyclical beneficiary of resurgent demand, building from the 1.22 billion US dollars base in the prior quarter to a higher expected contribution this quarter. The implied double-digit revenue growth in the financial forecast suggests broad-based recovery in capital equipment budgets across core end-markets. As supply constraints ease and channel inventory rebalances, the company can convert backlog into revenue with better gross margin capture, aided by a stable services mix and disciplined pricing. Over the medium term, continued innovation in chromatography and mass spectrometry systems should sustain upgrade cycles and drive higher-margin consumables pull-through.

Key stock price drivers this quarter

Near-term equity performance will hinge on the balance between revenue acceleration and margin progression against consensus, with particular focus on adjusted EPS conversion. Investors will scrutinize whether gross profit margin trends advance from the prior quarter’s 53.98% level given improved scale and mix. Another determinant is net profitability optics versus the prior quarter’s reported negative net income, as cleaner below-the-line items and normalized expenses could help narrow the gap between GAAP and adjusted results. Finally, commentary on order trends and the pacing of backlog conversion will influence how durable the recovery is perceived into the next quarter.

Analyst Opinions

A majority of recent institutional commentary is constructive, emphasizing a rebound in instrument demand and operating leverage translating to higher EPS in the near term. Several large sell-side houses highlight upside risk to revenue versus last year’s comparable period given the 124.56% year-over-year revenue growth embedded in forecasts, alongside EBIT growth of 115.23% and EPS growth of 24.76%. The bullish view argues that improved shipment cadence and a healthy service baseline create a more predictable earnings path, while margin recovery offers additional upside if pricing and mix hold. These institutions also point out that the prior quarter’s adjusted EPS growth and revenue beat establish a rising baseline into the print, reinforcing confidence that Waters can deliver above-trend profitability as supply-demand dynamics normalize.